LLMpediaThe first transparent, open encyclopedia generated by LLMs

Interpeduncular nucleus

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: VTA Hop 4
Expansion Funnel Raw 57 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted57
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Interpeduncular nucleus
NameInterpeduncular nucleus
LatinNucleus interpeduncularis
LocationMidbrain
InputsHabenular nuclei
OutputsRaphe nuclei, periaqueductal gray
NeurotransmittersAcetylcholine, GABA, Substance P

Interpeduncular nucleus is a compact, midline structure in the ventral midbrain situated between the cerebral peduncles that integrates signals from limbic forebrain centers and brainstem modulatory nuclei. It receives major input from the habenular complex and projects to raphe and periaqueductal regions, placing it at the interface of circuits implicated in mood, reward, aversion, and autonomic regulation. The nucleus is conserved across vertebrates and has been studied in contexts ranging from developmental neurobiology to psychiatric disorders.

Anatomy

The nucleus lies in the floor of the third ventricle at the level of the midbrain tegmentum and is bounded laterally by the cerebral peduncles and rostrally by the posterior commissure; its location has been delineated in atlases by investigators associated with the Harvard Medical School, Cold Spring Harbor Laboratory, and the Max Planck Society. Gross anatomical subdivisions include rostral, caudal, and ventromedial components that correspond to cytoarchitectonic maps generated by teams at the National Institutes of Health, Salk Institute, and the University of Oxford. Histological stains from laboratories linked to the Karolinska Institute and the University of Cambridge reveal densely packed neurons with distinct cholinergic and GABAergic populations, and vascularization patterns noted in reports from the World Health Organization.

Connections

Afferent projections arise predominantly from the medial and lateral habenular nuclei, which are targets of fibers from limbic structures such as the septal nuclei, nucleus accumbens, and the ventral pallidum studied by groups at the University of California, San Francisco and Johns Hopkins University. Efferent outputs target midbrain raphe nuclei, including the dorsal and median raphe linked to research at the Max Planck Institute for Neurobiology and to the periaqueductal gray as characterized by investigators at the University of Pennsylvania and the University College London. Reciprocal connectivity with the ventral tegmental area and modulatory interactions with the locus coeruleus have been described in work from the Massachusetts Institute of Technology and Columbia University. Tract-tracing studies from laboratories at the University of California, Los Angeles and the National Institute of Mental Health have detailed ascending and descending fibers that link the nucleus to the hypothalamus, including the paraventricular nucleus of the hypothalamus and the lateral hypothalamic area.

Development

Developmental origins trace to the ventral rhombencephalic and mesencephalic alar and basal plates in embryos examined in models from the European Molecular Biology Laboratory and the Stowers Institute for Medical Research. Gene expression patterns implicate transcription factors such as Nkx2.1, Pax6, and Otx2 identified in screens at the Broad Institute and in projects affiliated with the Wellcome Trust Sanger Institute. Developmental signaling pathways involving Sonic hedgehog and Wnt family members have been characterized in studies from the Howard Hughes Medical Institute and the Pasteur Institute, while lineage tracing in zebrafish and mouse models by the California Institute of Technology and Princeton University has delineated timing of habenular-to-interpeduncular axon formation critical for circuit maturation.

Neurochemistry and Cell Types

Cellular phenotypes include cholinergic neurons expressing choline acetyltransferase, GABAergic interneurons labelled by glutamate decarboxylase detected in collaborations with the National Academy of Sciences and the Chinese Academy of Sciences, and peptidergic cells that express substance P and neuropeptide Y studied at the Institut Pasteur and King's College London. Monoaminergic modulation arises via serotonergic inputs from raphe nuclei and noradrenergic influence from the locus coeruleus, intersections explored by teams at the University of Toronto and University of Melbourne. Receptor distributions include nicotinic acetylcholine receptor subunits that have been targets of pharmacology groups at Pfizer, Novartis, and academic laboratories at the University of Freiburg.

Function and Behavioral Roles

The nucleus is implicated in aversive learning, reward prediction, and the behavioral responses to nicotine and other drugs of abuse, with seminal behavioral paradigms developed at the Scripps Research Institute, Yale University, and the University of Michigan. Lesion and optogenetic studies from laboratories at the University of California, Berkeley and MIT show roles in conditioned taste aversion, anxiety-related behaviors, and modulation of serotonergic tone that influence depressive-like phenotypes explored by researchers at the National Institute of Mental Health and Cold Spring Harbor Laboratory. Functional imaging and electrophysiological recordings linked to projects at the Beth Israel Deaconess Medical Center and UCLA Neuropsychiatric Institute support involvement in decision-making circuits that include the prefrontal cortex and the amygdala.

Clinical Significance and Pathology

Dysfunction of interpeduncular circuits has been associated with nicotine dependence, depressive disorders, and certain movement disorders, themes pursued by consortia involving the World Health Organization, National Institutes of Health, and pharmaceutical partnerships with GlaxoSmithKline. Neuropathological changes have been observed in postmortem studies from the Mayo Clinic and the Mount Sinai Health System, and altered connectivity has been reported in neuroimaging studies conducted at Massachusetts General Hospital and the Karolinska Institute in cohorts with major depressive disorder and substance use disorders. Experimental therapeutics targeting nicotinic receptors and habenular-interpeduncular signaling pathways are in preclinical development at institutions including the Salk Institute and industrial collaborators such as Bristol-Myers Squibb.

Category:Brainstem nuclei